BiVictrix Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Public
  • Employees
  • 6
Employees
  • Stock Symbol
  • MTFBF
Stock Symbol
  • Investments
  • 1

BiVictrix Therapeutics General Information

Description

BiVictriX Therapeutics PLC is a drug development company. It has developed its proprietary Bi-Cygni technology which utilises Antibody Drug Conjugates for the treatment of various cancers including Acute Myeloid Leukaemia. The main country of operation is in the UK.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Discovery Tools (Healthcare)
Biotechnology
Stock Exchange
GREY
Primary Office
  • Bio Hub, Alderley Park
  • Cheshire
  • Alderley Edge SK10 4TG
  • England, United Kingdom

BiVictrix Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BiVictrix Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BiVictrix Therapeutics‘s full profile, request access.

Request a free trial

BiVictrix Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore BiVictrix Therapeutics‘s full profile, request access.

Request a free trial

BiVictrix Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Tiffany Thorn Founder, Board Member & Chief Executive Officer
Patrick Molyneux Secretary
Patrick Molyneux Secretary
You’re viewing 3 of 6 executive team members. Get the full list »

BiVictrix Therapeutics Board Members (7)

Name Representing Role Since
Michael Carter BiVictrix Therapeutics Board Member 000 0000
Norman Molyneux Acceleris Capital Chairman 000 0000
Tiffany Thorn BiVictrix Therapeutics Founder, Board Member & Chief Executive Officer 000 0000
You’re viewing 3 of 7 board members. Get the full list »

BiVictrix Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BiVictrix Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BiVictrix Therapeutics‘s full profile, request access.

Request a free trial

BiVictrix Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000 15-Jun-2021 000000000000000000 Holding Companies
To view BiVictrix Therapeutics’s complete acquisitions history, request access »